Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ralph Eberhard Graichen"'
Autor:
Robert Zweigerdt, Set Yen Soo, Ralph Eberhard Graichen, Christine L. Mummery, Su Chin Tham, Thavamalar Balakrishnan, Siti Norfiza, Alan Colman, Bruce Paul Davidson, Xiuqin Xu, Shirly Sieh, Stefan R. Braam
Publikováno v:
Differentiation, 76(4), 357-370. Elsevier B.V.
Human embryonic stem cells (hESC) can differentiate to cardiomyocytes in vitro but with generally poor efficiency. Here, we describe a novel method for the efficient generation of cardiomyocytes from hESC in a scalable suspension culture process. Dif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4060f28745c4565b8f37622c30c6f51e
https://doi.org/10.1111/j.1432-0436.2007.00236.x
https://doi.org/10.1111/j.1432-0436.2007.00236.x
Autor:
A. Colman, Z.X. Ngoh, Ralph Eberhard Graichen, Xiuqin Xu, William Sun, Bruce Paul Davidson, S.C. Tham, Robert Zweigerdt, S.T. Wang, S.Y. Soo
Publikováno v:
Cytotherapy. 10(4)
Current efforts to direct differentiation of human embryonic stem cells (hESC) into a particular cell lineage usually lead to a heterogeneous cell population with only a fraction of the desired cell type present. We show the generation of an essentia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3950201dbf85581848b863861f49985f
https://pubmed.ncbi.nlm.nih.gov/18574770
https://pubmed.ncbi.nlm.nih.gov/18574770
Autor:
Siti Norfiza Bte Rahmat, Thavamalar Balakrishnan, Ralph Eberhard Graichen, Alan Colman, Robert Zweigerdt, Jennifer C. Moore, Bruce Paul Davidson, Set Yen Soo, Christine L. Mummery, Su Chin Tham, Xiuqin Xu, Christian Freund, Shirly Sieh
Publikováno v:
Differentiation, 76, 958-970. Elsevier B.V.
Many applications of human embryonic stem cells (hESCs) will require fully defined growth and differentiation conditions including media devoid of fetal calf serum. To identify factors that control lineage differentiation we have analyzed a serum-fre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52c6c71d1bee34d5f8564a65bebf1b48
https://pubmed.ncbi.nlm.nih.gov/18557764
https://pubmed.ncbi.nlm.nih.gov/18557764
Autor:
Robert Zweigerdt, Ralph Eberhard Graichen, Martin F. Pera, Michael Rubart, Gregory L. Kay, Sean Reuter, Alan Colman, Bruce Paul Davidson, Sharon L. Hale, Robert A. Kloner, Wangde Dai, Loren J. Field, Aarne Jyrala
Human embryonic stem cell (hESC)-derived cardiomyocytes are a promising cell source for cardiac repair. Whether these cells can be transported long distance, survive, and mature in hearts subjected to ischemia/reperfusion with minimal infarction is u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7887a1c9718129b88241032819072870
https://europepmc.org/articles/PMC2796607/
https://europepmc.org/articles/PMC2796607/
Publikováno v:
Trends in biotechnology. 25(1)
Recent developments in the identification, in vitro culture and differentiation of stem cells point to the unprecedented potential of these cells, or their derivatives, to cure degenerative disorders. Human embryonic stem cells (hESC) offer the parti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ded5e48161c3000e6b6fa985a4005130
https://pubmed.ncbi.nlm.nih.gov/17084475
https://pubmed.ncbi.nlm.nih.gov/17084475